Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.15 - $3.34 $28,854 - $83,803
-25,091 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.96 - $7.76 $5,227 - $13,704
-1,766 Reduced 6.58%
25,091 $77,000
Q4 2021

Feb 11, 2022

SELL
$7.4 - $11.66 $1,931 - $3,043
-261 Reduced 0.96%
26,857 $199,000
Q3 2021

Nov 12, 2021

BUY
$9.18 - $14.15 $4,498 - $6,933
490 Added 1.84%
27,118 $313,000
Q2 2021

Aug 13, 2021

SELL
$8.07 - $12.52 $3,776 - $5,859
-468 Reduced 1.73%
26,628 $333,000
Q1 2021

May 07, 2021

BUY
$8.57 - $15.79 $608 - $1,121
71 Added 0.26%
27,096 $280,000
Q4 2020

Feb 12, 2021

SELL
$5.98 - $12.47 $4,634 - $9,664
-775 Reduced 2.79%
27,025 $225,000
Q3 2020

Nov 04, 2020

SELL
$4.65 - $8.73 $590 - $1,108
-127 Reduced 0.45%
27,800 $171,000
Q2 2020

Aug 12, 2020

BUY
$4.66 - $8.7 $31,030 - $57,933
6,659 Added 31.31%
27,927 $233,000
Q1 2020

May 04, 2020

SELL
$5.05 - $15.01 $6,206 - $18,447
-1,229 Reduced 5.46%
21,268 $128,000
Q4 2019

Feb 05, 2020

BUY
$6.32 - $19.66 $105,607 - $328,518
16,710 Added 288.75%
22,497 $312,000
Q3 2019

Nov 08, 2019

SELL
$8.03 - $14.82 $321 - $592
-40 Reduced 0.69%
5,787 $49,000
Q2 2019

Aug 13, 2019

BUY
$11.88 - $16.94 $69,224 - $98,709
5,827 New
5,827 $77,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $499M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.